IRF1 regulates the progression of colorectal cancer via interferon‑induced proteins

X Xu, Y Wu, K Yi, Y Hu, W Ding… - … journal of molecular …, 2021 - spandidos-publications.com
Radiation is one of the main methods for the treatment of colorectal cancer (CRC) before or
after surgery. However, radiotherapy tolerance of patients with CRC is often a major …

[HTML][HTML] ATPase inhibitory factor 1 expression is an independent prognostic factor in non-small cell lung cancer

YX Gao, L Chen, XG Hu, HB Wu, YH Cui… - American journal of …, 2016 - ncbi.nlm.nih.gov
Abstract ATPase inhibitory factor 1 (IF1), an inhibitor of the mitochondrial H+-adenosine
triphosphate (ATP) synthase, is putatively involved in tumor progression. This study aimed to …

Prognostic value of RILPL2 and its correlation with tumor immune microenvironment and glycolysis in non-small cell lung cancer

D Chen, H Zhang, L Zhao, X Liu, S Xue, P Wu, H Jiang - Cell Cycle, 2023 - Taylor & Francis
Rab-interacting lysosomal protein–like 2 (RILPL2) has been reported to be associated with
prognosis and tumor biological functions in breast cancer and endometrial carcinoma …

Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican

D Brunn, K Turkowski, S Günther, A Weigert, T Muley… - Cancers, 2021 - mdpi.com
Simple Summary Lung cancer is the leading cause of cancer-related deaths worldwide,
accounting for more than 1.6 million deaths per year. The tumor microenvironment (TME) …

[HTML][HTML] The KLF6 splice variant KLF6-SV1 promotes proliferation and invasion of non-small cell lung cancer by up-regultating PI3K-AKT signaling pathway

N Zhang, QQ Yan, L Lu, JB Shao, ZG Sun - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is an aggressive type of lung malignancy. Most of the
patients have poor prognosis. Increasing evidence has revealed an association between …

The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells

J Wan, J Ma, J Mei, G Shan - Journal of Experimental & Clinical Cancer …, 2009 - Springer
Background Gene targeted therapy refers to any therapy focused on one of the many
biological features of the tumor. Such features are mediated by specific genes that are …

Overexpression of eIF5A‐2 is an adverse prognostic marker of survival in stage I non–small cell lung cancer patients

LR He, HY Zhao, BK Li, YH Liu, MZ Liu… - … Journal of Cancer, 2011 - Wiley Online Library
We have previously isolated an oncogene EIF5A2 (eukaryotic initiation factor 5A2) from a
frequently amplified region at 3q of a primary ovarian cancer cell line, and demonstrated its …

[HTML][HTML] Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer

JS Kim, ES Kim, D Liu, JJ Lee, C Behrens… - Oncotarget, 2015 - ncbi.nlm.nih.gov
According to previous reports demonstrating the implication of insulin-like growth factor
receptor (IGF-1R) signaling in non-small cell lung cancer (NSCLC), in this study, the …

Interferon-induced transmembrane protein 1 (IFITM1) promotes distant metastasis of small cell lung cancer

S Sakamoto, H Inoue, Y Kohda, S Ohba… - International Journal of …, 2020 - mdpi.com
Small cell lung cancer (SCLC) is a severe malignancy associated with early and widespread
metastasis. To study SCLC metastasis, we previously developed an orthotopic …

Interferon alpha-inducible protein 27 promotes epithelial–mesenchymal transition and induces ovarian tumorigenicity and stemness

S Li, Y Xie, W Zhang, J Gao, M Wang, G Zheng… - Journal of Surgical …, 2015 - Elsevier
Background Interferon alpha-inducible protein 27 (IFI27) is an interferon alpha-inducible
protein, which was found to be upregulated in some cancers, such as breast cancer …